Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-078328
Filing Date
2022-03-17
Accepted
2022-03-17 16:21:35
Documents
5
Effectiveness Date
2022-03-17

Document Format Files

Seq Description Document Type Size
1 S-8 d275817ds8.htm S-8 36625
2 EX-5.1 d275817dex51.htm EX-5.1 5477
3 EX-23.1 d275817dex231.htm EX-23.1 1895
4 EX-FILING FEES d275817dexfilingfees.htm EX-FILING FEES 15505
5 GRAPHIC g275817g43v11.jpg GRAPHIC 3105
  Complete submission text file 0001193125-22-078328.txt   64895
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263640 | Film No.: 22748842
SIC: 2836 Biological Products, (No Diagnostic Substances)